DXCM
$80.04
Revenue | $994.2Mn |
Net Profits | $134.6Mn |
Net Profit Margins | 13.54% |
Dexcom, Inc.’s revenue jumped 1.97% since last year same period to $994.2Mn in the Q3 2024. On a quarterly growth basis, Dexcom, Inc. has generated -1.01% fall in its revenue since last 3-months.
Dexcom, Inc.’s net profit jumped 11.52% since last year same period to $134.6Mn in the Q3 2024. On a quarterly growth basis, Dexcom, Inc. has generated -6.2% fall in its net profits since last 3-months.
Dexcom, Inc.’s net profit margin jumped 9.36% since last year same period to 13.54% in the Q3 2024. On a quarterly growth basis, Dexcom, Inc. has generated -5.25% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.52 |
EPS Estimate Current Year | 0.52 |
Dexcom, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.52 - a 18.18% jump from last quarter’s estimates.
Dexcom, Inc.’s earning per share (EPS) estimates for the current year stand at 0.52.
Earning Per Share (EPS) | 0.45 |
Dexcom, Inc.’s earning per share (EPS) fell -10% since last year same period to 0.45 in the Q3 2024. This indicates that the Dexcom, Inc. has generated -10% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-04-25 | 0.27 | 0.32 | 18.52% |
2024-07-25 | 0.39 | 0.43 | 10.26% |
2024-10-24 | 0.44 | 0.45 | 2.27% |